MedicalXpress.com – Vaccines

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the current endemic status of COVID-19, patients with comorbidities and […]

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with […]

Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of serious side effects; the other, which is newer and made with […]

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine composition designed to be administered via the nose. Griffith University Principal Research Leader, Professor Bernd Rehm said […]

A new World Health Organization (WHO) study published in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development. The WHO study is the first global effort to […]

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA COVID-19 and inactivated influenza vaccines simultaneously had no more adverse effects than those who received the […]

Seasonal influenza epidemics impose substantial burdens on health care systems and cause >5 million hospitalizations of adults each year. The current approach to influenza vaccine development requires comprehensive surveillance of circulating strains, which are constantly […]

A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) sheds light on public trust in COVID-19 vaccine science […]

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines. In a recent commentary published in The Lancet, Angela Branche, MD, an infectious diseases researcher […]

Vaccinating children under five-years-old in endemic mpox regions in the Democratic Republic of the Congo (DRC) would significantly reduce the number of deaths in the country, according to an analysis by researchers at the Yale […]